SNORD33 and non-small cell lung carcinoma: Also, SNORD33, SNORD66, and SNORD76 are highly expressed in non-small-cell lung cancer (NSCLC) patients’ plasma, serving as sensitive and specific markers for NSCLC [162], which causes about 25% of cancer-related deaths.